"Big Pharma" in the eyes of the public is two related but separate issues; 1) the weird employment-insurance-hospital loop that has developed in the US, and the terrible second-order-consequences of all the open-high/settle-low insurer carer system it led to, and 2) the medicine advertisements, and all the terrible consequences thereof. The second one seems like a much easier thing to get rid of using hard government…
Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
381–390 of 595 posts
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#382Earlier quoted context omitted.
In 2018, the average insulin price in the US was $98.70, compared to $6.94 in Australia, $12.00 in Canada, and $7.52 in the UK. This is a 100 year old drug.
It isn't a 100 year old drug. There are newer formulations that are faster acting, longer lasting, easier to administer, etc. They're newer so they're still under patent so they're a lot more expensive (because the rest of the world makes the US pay to develop the newer formulations). When insurance is paying for it, people prefer the newer formulations. Then, since most people have insurance, there wasn't enough of…
The prices of insulin have been increased steadily each year by about 11% for the past 20 years. There's nothing about research or costs that justify that for 20 year old drugs.
https://www.businessinsider.com/insulin-price-increased-last...
The old formulations (Human insulin, NPH) can be purchased without a prescription at Walmart for fairly low prices - the price that people pay for modern insulin in the rest of the world.
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#383here [1] they say that Kamala Harris is seen as a friend of big tech and silicon valley, that would imply she is a friend of big tech corporations. Does this step signify a rift between Biden and Harris, or is that not the case? [1] http://web.archive.org/web/20210206212101/https://www.nytime...
That’s possible but the article is a year old. This past year and a half I think if you polled the HN crowd you would even see a dramatic shift in perspective on proper policy for big tech antitrust legislation. It is not unreasonable to assume those same realizations are happening or being expressed by government officials as well.
[1] https://abcnews.go.com/Politics/wireStory/biden-offers-tax-d...
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#384Earlier quoted context omitted.
There is also a third issue: The high cost of medicines that are low cost to produce, and are sold at low cost elsewhere
This one is particularly prickly because the high cost paid in the US funds medical R&D and extremely expensive clinical trials which other countries are free riding on by imposing price controls. We still need to fund the R&D and clinical trials (unless they could be made less expensive somehow), so the most obvious solution would be to have other countries pay their fair share so the US could stop subsidizing every…
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#385"Big Pharma" in the eyes of the public is two related but separate issues; 1) the weird employment-insurance-hospital loop that has developed in the US, and the terrible second-order-consequences of all the open-high/settle-low insurer carer system it led to, and 2) the medicine advertisements, and all the terrible consequences thereof. The second one seems like a much easier thing to get rid of using hard government…
What the public does not see is how the patent system is gamed by generic sellers. How this works is not something that can be easily explained in a single paragraph.
The problem is specifically mentioned in the Fact Sheet/Order. This is a legitimate antitrust issue but it is exceedingly difficult to succeed in the courts.
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#386Earlier quoted context omitted.
It isn't a 100 year old drug. There are newer formulations that are faster acting, longer lasting, easier to administer, etc. They're newer so they're still under patent so they're a lot more expensive (because the rest of the world makes the US pay to develop the newer formulations). When insurance is paying for it, people prefer the newer formulations. Then, since most people have insurance, there wasn't enough of…
> Then, since most people have insurance, there wasn't enough of a market for the older formulations for anybody to bother making them for the margins you get for making a generic. Is there some research confirming that? It doesn't quite match my out-of-us experience with other drugs. I get a choice of 2-3 brands of ibuprofen and another 1-2 generics for it. Why wouldn't the same apply to insulin? I expect that it's…
For modern insulin, they were indeed patented but mostly generics called follow-ons or biosimilars are available. Lantus has an alternative Basaglar that costs about 1/3 as a much. Humalog can be replaced with Admelog. The manufacturer of Novolog makes a biosimilar of their own insulin and sells it for 1/3 as much, if that makes any sense.
The various types differ a bit... Lantus has a slower absorption and thus longer duration than it's main competitor, Levemir. Novolog differs from Humalog in one protein on one side of the chain or something. Some people can't use one or the other due to allergies to the excipients or unexplained resistance to the effects.
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#387Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#388Earlier quoted context omitted.
There is also a third issue: The high cost of medicines that are low cost to produce, and are sold at low cost elsewhere
This one is particularly prickly because the high cost paid in the US funds medical R&D and extremely expensive clinical trials which other countries are free riding on by imposing price controls. We still need to fund the R&D and clinical trials (unless they could be made less expensive somehow), so the most obvious solution would be to have other countries pay their fair share so the US could stop subsidizing every…
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#389Earlier quoted context omitted.
You are off by a factor 10. The 1 billion is in total over all the time needed to produce the drug (about 10 years), while ads are per year.
ok, so 65 drugs in development, with 6.5 drugs released per year? does that seem plausible for the entire pharma industry?
https://www.statista.com/statistics/817534/annual-novel-drug...
Re: Biden launches action on "Big Tech, Big Pharma, and Big Ag" – can it be real?
#390Earlier quoted context omitted.
There is also a third issue: The high cost of medicines that are low cost to produce, and are sold at low cost elsewhere
This one is particularly prickly because the high cost paid in the US funds medical R&D and extremely expensive clinical trials which other countries are free riding on by imposing price controls. We still need to fund the R&D and clinical trials (unless they could be made less expensive somehow), so the most obvious solution would be to have other countries pay their fair share so the US could stop subsidizing every…
Most of those money goes on marketing.
Moreover, I think that US citizens did not signed up to pay medical R&D for whole world while they are sick. In fact, US citizens tend to have issues with paying researcher, social support and so on from their money.
R&D paid from taxes or insurance makes way more sense then paid by those who already deal with health crisis.